Literature DB >> 32195710

Rural-Urban Differences in Neuroimmune Biomarkers and Health Status Among Women Living With Breast Cancer.

Jennifer M Hulett1, Demetrius A Abshire, Jane M Armer, Rami Millspaugh, Joshua Millspaugh.   

Abstract

BACKGROUND: Because of chronic emotional and psychosocial stressors following breast cancer (BC) treatment, BC survivors are at risk of neuroimmune dysfunction in survivorship. Rural BC survivors experience more health disparities than urban BC survivors. Rural-urban residence as a variable on neuroimmune activity in extended BC survivorship continuum has not been explored.
OBJECTIVE: To report the feasibility of studying relationships between neuroimmune activity and perceived health in rural and urban BC survivors.
METHODS: Data from a pilot study of BC survivors (n = 41) were analyzed. Participants were rural (n = 16) and urban (n = 25). Participants completed Medical Outcomes Study Short-Form Version 2 Health Survey questionnaires and provided salivary specimens for analysis of salivary α-amylase (sAA), cortisol, and interleukin 6 (IL-6). Rural-Urban Commuting Area Codes were used to determine rural or urban residence.
RESULTS: Differences in immune activity were observed between rural and urban BC survivors (U = 34, P < .05). No rural-urban group differences in neuroendocrine activity were observed. Relationships were observed between perceptions of mental health and sAA (P < .05) in rural BC survivors and between perceptions of mental health and IL-6 (P < .05) in urban BC survivors. Interleukin 6 was positively associated with perceptions of physical health (P < .05) in rural BC survivors.
CONCLUSION: Pilot data suggest rural-urban residence may be a factor in relationships between neuroimmune function (ie, sAA and IL-6) and perceived health status, particularly social functioning in women with BC. Additional studies with powered designs are indicated. IMPLICATIONS FOR PRACTICE: Although evidence is limited, data support the feasibility of studying relationships between sAA and IL-6 and perceptions of health in women with BC.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 32195710      PMCID: PMC8628188          DOI: 10.1097/NCC.0000000000000802

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN: 0162-220X            Impact factor:   2.592


  51 in total

Review 1.  How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions.

Authors:  R M Sapolsky; L M Romero; A U Munck
Journal:  Endocr Rev       Date:  2000-02       Impact factor: 19.871

2.  Effects of mindfulness-based stress reduction (MBSR) on health among breast cancer survivors.

Authors:  Yaowarat Matchim; Jane M Armer; Bob R Stewart
Journal:  West J Nurs Res       Date:  2010-10-18       Impact factor: 1.967

3.  Does distance matter? Distance to mammography facilities and stage at diagnosis of breast cancer in Kentucky.

Authors:  Bin Huang; Mark Dignan; Daikwon Han; Owen Johnson
Journal:  J Rural Health       Date:  2009       Impact factor: 4.333

Review 4.  Role of interleukin-6 in stress, sleep, and fatigue.

Authors:  Nicolas Rohleder; Martin Aringer; Matthias Boentert
Journal:  Ann N Y Acad Sci       Date:  2012-07       Impact factor: 5.691

5.  Psychologic stress, reduced NK cell activity, and cytokine dysregulation in women experiencing diagnostic breast biopsy.

Authors:  Linda Witek-Janusek; Sheryl Gabram; Herbert L Mathews
Journal:  Psychoneuroendocrinology       Date:  2006-11-07       Impact factor: 4.905

Review 6.  Salivary cortisol as a biomarker in stress research.

Authors:  Dirk H Hellhammer; Stefan Wüst; Brigitte M Kudielka
Journal:  Psychoneuroendocrinology       Date:  2008-12-18       Impact factor: 4.905

Review 7.  Salivary markers of inflammation in response to acute stress.

Authors:  Danica C Slavish; Jennifer E Graham-Engeland; Joshua M Smyth; Christopher G Engeland
Journal:  Brain Behav Immun       Date:  2014-09-07       Impact factor: 7.217

8.  Co-morbidity and predictors of health status in older rural breast cancer survivors.

Authors:  Andres Azuero; Rachel Benz; Patrick McNees; Karen Meneses
Journal:  Springerplus       Date:  2014-02-20

Review 9.  Use of Salivary Diurnal Cortisol as an Outcome Measure in Randomised Controlled Trials: a Systematic Review.

Authors:  Richella Ryan; Sara Booth; Anna Spathis; Sarah Mollart; Angela Clow
Journal:  Ann Behav Med       Date:  2016-04

10.  Salivary Alpha-Amylase Reactivity in Breast Cancer Survivors.

Authors:  Cynthia Wan; Marie-Ève Couture-Lalande; Tasha A Narain; Sophie Lebel; Catherine Bielajew
Journal:  Int J Environ Res Public Health       Date:  2016-03-23       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.